Sanofi's antibody riliprubart has received orphan drug designation from Japan's MHLW for its potential to treat CIDP.

AbbVie gains control of an in vivo CAR-T therapy that could overcome limitations with currently approved autologous ...

Piramal Pharma invests $90m to expand its two US facilities, enhancing manufacturing capabilities for sterile injectables and ...

Proposals for drug exclusivities and feeble measures to combat drug shortages are unlikely to boost innovation, say some ...

The FDA has approved Takeda’s new immunoglobulin therapy, Gammagard liquid ERC [immune globulin infusion (human)], to treat ...

WHO director Dr Tedros Adhanom Ghebreyesus says all hypotheses are on the table, as the organisation works to reinforce ...